Deficit of IgG2 in HIV-positive pregnant women is responsible of inadequate IgG2 levels in their HIV-uninfected children in Malawi

Medical Microbiology and Immunology
Silvia BaroncelliMarina Giuliano

Abstract

Transplacental passage of IgGs is impaired in HIV + pregnant women, possibly determining an inadequate immunological protection in their children. We aimed to determine the impact of maternal immunological IgG profile and immunoactivation status on the efficiency of transplacental passage of IgG subclasses in HIV + mothers. 16 mother/infants pairs were studied in Malawi. Mothers received antiretroviral therapy (ART) from the third trimester of pregnancy. Determinations of pre-ART levels of maternal sCD14, of IgG subclasses in mothers at delivery and in their 1-month-old infants, were performed using commercial ELISA kits. At delivery, after a median of 10 weeks of ART, 12/16 mothers were hypergammaglobulinemic, with IgG levels (20.5 mg/ml, 95% CI:18.8-26.8) directly correlated to the plasmatic levels of sCD14 (r = 0.640, p = 0.014). IgG1 levels (17.9 mg/ml) accounted for 82% of IgG, IgG3 and IgG4 levels were in the normal range. A profound deficit of IgG2 was observed both in mothers (0.60 mg/ml) and in infants (0.14 mg/ml). Placental transfer ratio (range 0.16-0.42) did not show a selective impairment between the different IgG subclasses. The transplacental passage of all IgG subclasses was decreased in the presence of materna...Continue Reading

References

Sep 17, 1970·The New England Journal of Medicine·P H SchurF S Rosen
May 1, 1996·The Journal of Infectious Diseases·M I de Moraes-PintoC A Hart
Apr 9, 1999·Archives of Disease in Childhood. Fetal and Neonatal Edition·M I de Moraes-PintoC A Hart
Sep 15, 2000·Pediatrics International : Official Journal of the Japan Pediatric Society·S HashiraK Yoshino
Jul 10, 2003·Vaccine·Neil E Simister
Nov 11, 2005·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Carey FarquharGrace John-Stewart
Aug 19, 2006·Journal of Leukocyte Biology·Anne Hosmalin, Pierre Lebon
Nov 23, 2006·Nature Medicine·Jason M BrenchleyDaniel C Douek
Feb 5, 2008·The Journal of Infectious Diseases·Susan MoirAnthony S Fauci
Mar 26, 2009·Nature Reviews. Immunology·Susan Moir, Anthony S Fauci
May 7, 2009·Proceedings of the National Academy of Sciences of the United States of America·Simone PensierosoPaolo Rossi
Apr 29, 2010·Current HIV/AIDS Reports·Linda L Baum
Feb 10, 2011·JAMA : the Journal of the American Medical Association·Christine E JonesAnneke C Hesseling
Jan 12, 2012·Clinical & Developmental Immunology·Patricia PalmeiraMagda Carneiro-Sampaio
Jan 1, 2011·Frontiers in Immunology·Nicolas RuffinFrancesca Chiodi
Jun 30, 2012·Cytokine & Growth Factor Reviews·Morgan A ReuterMichael R Betts
Nov 20, 2013·Pathology·Andrew McLean-TookeRichard Loh
Dec 12, 2013·Clinical and Experimental Immunology·L AfranS L Rowland-Jones
Nov 5, 2014·Frontiers in Immunology·Gestur VidarssonTheo Rispens
Jan 16, 2015·Medicine·Haoze ZhangQun Shi
Jan 27, 2016·Current HIV/AIDS Reports·Michael L FreemanSara Gianella
Sep 16, 2016·Frontiers in Immunology·Bahaa Abu-RayaArnaud Marchant
Oct 21, 2016·Tropical Medicine & International Health : TM & IH·A L WilkinsonJ M McDermid
Jan 1, 2017·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ramla F TankoWendy A Burgers
Sep 9, 2017·Tropical Diseases, Travel Medicine and Vaccines·Ziyaad DangorShabir A Madhi

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA

Software Mentioned

SPSS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.